טוען...
Promising potential of [(177)Lu]Lu-DOTA-folate to enhance tumor response to immunotherapy—a preclinical study using a syngeneic breast cancer model
PURPOSE: It was previously demonstrated that radiation effects can enhance the therapy outcome of immune checkpoint inhibitors. In this study, a syngeneic breast tumor mouse model was used to investigate the effect of [(177)Lu]Lu-DOTA-folate as an immune stimulus to enhance anti-CTLA-4 immunotherapy...
שמור ב:
| הוצא לאור ב: | Eur J Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Springer Berlin Heidelberg
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8041666/ https://ncbi.nlm.nih.gov/pubmed/33078260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-020-05054-9 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|